Olympus launches unit to serve
MARKHAM, Ont. – Olympus, a precision technology leader
designing and delivering imaging solutions in healthcare, life science
and photography, has announced the launch of Olympus Canada Inc. to
provide direct services to Olympus’ Canadian customers in the medical,
surgical, scientific, and industrial markets.
Glen Stalter, 45, has been appointed the first Executive Vice President
and Chief Operating Officer of Olympus Canada.
Over the past 58 years, Olympus and its customers were served by a
distributor in Canada. In order to help ensure a smooth transition, 98
percent of the former distributor’s sales and support staff have become
employees of Olympus Canada. Customers will also benefit from the
resources of the global Olympus network, including greater access to
educational support, international programs and courses, and the
opportunity to partner with Olympus for research projects and
advancements in clinical endoscopy applications.
“With a current endoscopy market share of nearly 80 percent and Olympus’
strong growth momentum in Canada, the launch of Olympus Canada comes at
the right time,” said F. Mark Gumz, President of Olympus Canada. Gumz,
who is also President and Chief Operating Officer of Olympus America
Inc., added, “Glen Stalter has been involved in every aspect of
transitioning the business to the new company. He is a consummate
professional, and I am pleased he is Olympus Canada’s first COO.”
Stalter has been an Olympus employee for nearly 13 years. Over the past
six years, he served as the executive of various corporate
responsibilities at Olympus America, including Finance, Operations,
Healthcare Services, and Financial Services.
“I would like to thank our Canadian customers for their support of the
Olympus line during the last half century,” said Stalter. “We look
forward to broadening our offerings with enhanced service lines and the
synergies now possible by working with our neighboring Olympus sister
Olympus Canada will continue supporting the adoption of new Olympus
products in the Canadian marketplace, such as the EVIS EXERA II 180, the
world’s first endoscope platform to deliver high-definition television (HDTV)and
Narrow Band Imaging (NBI) technologies to enhance visualization during
The universal platform also integrates surgical endoscopy, such as the
HD EndoEYE surgical videoscopes and medical endoscopy, into one complete
system for multiple specialties, e.g., general surgery, gastroenterology,
urology and gynecology.
Olympus Canada will also introduce additional Olympus products and
services to provide total solutions to Canadian GI facilities that
increase efficiency and clinical outcomes. Among the new offerings is
EndoSite Consulting, a comprehensive collection of professional services
for hospital GI labs, private endoscopy clinics and office endoscopy
Olympus Financial Services provides cost-effective, balance-sheet
sensitive solutions that enable healthcare professionals to maximize
market share, revenues and profits through the acquisition of Olympus
instrumentation, coupled with prudent asset management.
Another new service offered by Olympus Canada is Olympus University, an
extensive selection of endoscopy programs, providing continued medical
education (CME) and contact hour accredited live courses to physicians,
surgeons, nurses, technicians, biomedical engineers, administrators and
materials managers to further their knowledge of the industry.
Olympus willalso seek partnerships with Canadian healthcare
professionals to develop new product prototypes with Olympus research
and development, enabling customers to impact products in development by
providing early feedback, and to use the latest Olympus technologies
Donations to Canadian Colorectal Cancer Groups:
On the occasion of its launch, Olympus Canada is donating Cdn$15,000 to
each the Colorectal Cancer Association of Canada (CCAC) and Colorectal
Cancer Screening Initiative Foundation (CCSIF). Stalter will present
cheques to each organization at a special event at Ontario Science
Centre in Toronto.
“Olympus is committed to increasing the public’s awareness for the need
to be screened, and at the same time, we will be working together with
our customers to find ways to improve efficiencies so that more
Canadians can be screened,” added Stalter. “It’s our mission.”
This year, 20,000 Canadians will be diagnosed with colorectal cancer,
the second-leading cause of death from cancer, and 8,600 will die of it,
according to the Canadian Cancer Society.
About Olympus Canada
Olympus is a precision technology leader, designing and
delivering innovative solutions in healthcare, life science and
photography. Olympus Canada works collaboratively with its customers and
its ultimate parent company, Tokyo-based Olympus Corporation, to
leverage R&D investment in precision technology and manufacturing
processes across diverse business lines. These include:
• Gastrointestinal endoscopes, accessories, and minimally invasive
• Advanced clinical and research microscopes;
• Industrial imaging, including remote inspection, industrial microscopy
and real-time manufacturing inspection.
For more information, visit www.olympuscanada.com.